{"id":57911,"name":"CAMPAIGN FOR SUSTAINABLE DRUG PRICING (CSRXP)","slug":"campaign-for-sustainable-drug-pricing-csrxp","state":"DC","country":"United States of America","description":"Coalition to promote lowering prescription drug prices.","totalSpending":320000,"filings":10,"yearlySpending":[{"year":2023,"income":20000},{"year":2024,"income":100000},{"year":2025,"income":200000}],"issues":["MMM","CPT","PHA","TAX"],"firms":["WHITMER & WORRALL, LLC"],"lobbyists":["MARTIN WHITMER","THOMAS WORRALL","ERIK KOMENDANT"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Issues related to prescription drug prices. S.150 Affordable Prescriptions for Patients Act","Issues related to prescription drug prices. S.150 Affordable Prescriptions for Patients Act","Issues related to prescription drug prices. S.150 Affordable Prescriptions for Patients Act. S.935 Fair Accountability and Innovative Research Drug Pricing Act. S.1250/H.R.5958 Drug Price Transparency","Patent abuse issues. S. 150 Affordable Prescriptions for Patients Act of 2023. S. 79 Interagency Patent Coordination Act. S. 2780 Medication Affordability and Patent Integrity Act S. 142 Preserve Acce","Issues related to prescription drug pricing. S. 2305 Biosimilar Red Tape Elimination Act. S. 148 Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics Act. S. 1067 Ens"],"years":[2023,2024,2025]}